Evidence map›Paper›PMID 41013787›Full record

ReviewJournal of medical case reports2025

Emphysematous pyelonephritis in a diabetic child: a case report and review of the literature.

Behnaz Bazargani, Mastaneh Moghtaderi, Hassan Esfandiary, Fatemeh Ghanbarian, Noosha Samieefar

Abstract readCase ReportsReview
In one paragraph

Review in Journal of medical case reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Behnaz BazarganiPediatric Chronic Kidney Disease Research Center, Gene, Cell & Tissue Research Institute, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Mastaneh MoghtaderiPediatric Chronic Kidney Disease Research Center, Gene, Cell & Tissue Research Institute, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Hassan EsfandiaryPediatric Chronic Kidney Disease Research Center, Gene, Cell & Tissue Research Institute, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Fatemeh GhanbarianPediatric Chronic Kidney Disease Research Center, Gene, Cell & Tissue Research Institute, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran.
Noosha SamieefarPediatric Chronic Kidney Disease Research Center, Gene, Cell & Tissue Research Institute, Children's Medical Center, Tehran University of Medical Sciences, Tehran, Iran. Samieefar.PCKD@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionEmphysematous pyelonephritis is a life-threatening condition characterized by gas accumulation within the kidney and the surrounding tissues, often resulting in tissue necrosis. Although frequently reported in adults, emphysematous pyelonephritis is an extremely rare condition in children, with only a few documented cases in the literature. We present the case of a child with insulin-dependent diabetes mellitus who had initially been admitted with a diagnosis of diabetic ketoacidosis that was later revealed to be emphysematous pyelonephritis. CASE PRESENTATION: An Iranian 11-year-old girl with poorly controlled type 1 diabetes was referred to the Children's Medical Center with a computed tomography scan confirming emphysematous pyelonephritis (stage 4). The patient initially presented with abdominal and flank pain, fever, and fatigue, and the initial diagnosis was diabetic ketoacidosis. Despite undergoing management for diabetic ketoacidosis, the patient continued to exhibit signs of fever and illness. Further evaluation ruled out diabetic ketoacidosis, and active urine analysis indicated a kidney pathology. Imaging investigations confirmed the presence of gas within the pyelocaliceal system. In our center, the patient was treated with intravenous meropenem and vancomycin for 7 days and was discharged with improved health and normal kidney function.

conclusionThis case underscores the significance of considering emphysematous pyelonephritis in children, particularly those with underlying conditions such as diabetes, even when initial presentations suggest other diagnoses such as diabetic ketoacidosis.

Indexed as

Diabetes Mellitus, Type 1Diabetic KetoacidosisEmphysemaPyelonephritisAnti-Bacterial AgentsChildEmphysematous PyelonephritisFemaleHumansMeropenemTomography, X-Ray ComputedTreatment OutcomeVancomycinAnti-Bacterial AgentsMeropenemVancomycinCase reportChildDiabetes mellitusEmphysematous pyelonephritis

Identifiers

PMID41013787
PMCPMC12465383

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.